• Home
  • PANVIPREP
    Emerging RNA virusesAntiviral drugs PANVIPREP’s priority virus listPANVIPREP’s toolbox
  • Work Packages
    The PANVIPREP approachWP1 Project management and coordinationWP2 From new hits to early leadWP3 From hit to (new) validated targetWP4 From target to hitWP5 Dissemination, communication and exploitationWP6 Ethics
  • Partners
    PartnersTrack record
  • Products
    PANVIPREP impactTarget-based hitsNovel approaches
  • Publications
    Scientific publicationsPress releasesNewsletters
  • Communication
    MeetingsInterviewsCollaborationsContact Information
  1. Communication
  2. Interviews

Interviews

 

LUMC op Linkedin

https://www.linkedin.com/posts/lumc_eu-project-van-start-hoe-europa-zich-beter-activity-7173338271731568641-92mA?utm_source=share&utm_medium=member_desktop

 

Radio 1 Journaal

https://www.nporadio1.nl/fragmenten/nos-radio-1-journaal/d78f4018-d957-4d85-9bb6-ea50fe7fe93a/2024-03-12-hoe-ontwikkel-je-een-medicijn-voor-een-ziekte-die-je-nog-niet-kent

 

Leidsch Dagblad

Download hier het hele artikel uit het Leidsch Dagblad

 

 

This project has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement no. 101137229